Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis

MLA

Marius Horger, et al. “Successful Treatment with the IL12/IL23 Antagonist Ustekinumab in a Patient with Refractory Takayasu Arteritis.” Rheumatology Advances in Practice, vol. 5, Jan. 2021. EBSCOhost, https://doi.org/10.1093/rap/rkaa082.

APA

Marius Horger, Jörg Henes, & Sebastian-Jonas Saur. (2021). Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis. Rheumatology Advances in Practice, 5. https://doi.org/10.1093/rap/rkaa082

Chicago

Marius Horger, Jörg Henes, and Sebastian-Jonas Saur. 2021. “Successful Treatment with the IL12/IL23 Antagonist Ustekinumab in a Patient with Refractory Takayasu Arteritis.” Rheumatology Advances in Practice 5 (January). doi:10.1093/rap/rkaa082.